Hisamitsu Pharmaceutical Co (TSE:4530) Beta: N/A (As of Jun. 30, 2026)


TSE:4530 Hisamitsu Pharmaceutical Co Inc TSE:4530
68 GF Score
Price 円6,040.00
GF Value 円4,918.72
Valuation Modestly Overvalued
View Full Analysis

What is Hisamitsu Pharmaceutical Co Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-30), Hisamitsu Pharmaceutical Co's Beta is Not available.

Hisamitsu Pharmaceutical Co  (TSE:4530) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Hisamitsu Pharmaceutical Co Beta Related Terms

Hisamitsu Pharmaceutical Co Beta Historical Data

* Premium members only.

The historical data trend for Hisamitsu Pharmaceutical Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hisamitsu Pharmaceutical Co Beta Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.98 0.77 0.14 -0.01 -0.04

Hisamitsu Pharmaceutical Co Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.02 0.01 -0.16 -0.04
TSE:4530
68GF Score
Hisamitsu Pharmaceutical Co Inc TSE:4530
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hisamitsu Pharmaceutical Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Is Hisamitsu Pharmaceutical Co (TSE:4530) Overvalued in 2026?

Based on GuruFocus' analysis, Hisamitsu Pharmaceutical Co stock appears to be overvalued. The current stock price of 円6,040.00 is trading 22.8% above its estimated GF Value™ of 円4,918.72. GuruFocus considers Hisamitsu Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for TSE:4530:

  • Beta: N/A
  • GF Value™: 円4,918.72 vs. price of 円6,040.00 (22.8% above fair value)
  • GF Score™: 68/100

No single metric tells the full story. See the TSE:4530 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hisamitsu Pharmaceutical Co Business Description

Other Exchanges HTSUY:USA
Address 408 Tashiro Daikancho, Saga Prefecture, Tosu, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is engaged in the research, development, manufacturing, procurement, and sale of pharmaceutical products. The company operates a single business segment, focusing on medical and general pharmaceuticals both in Japan and overseas. It markets drugs under the Salonpas, Nobinobi / Salonsip, Butenalock, and Mohrus brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions, and ointments.
68GF Score

Get the complete analysis for TSE:4530

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円6,040.00
Price
円4,918.72
GF Value